MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
158 hedge funds and large institutions have $1.05B invested in Momenta Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 38 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
48% less capital invested
Capital invested by funds: $2.01B → $1.05B (-$954M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
158
Holding in Top 10
–
Calls
$771K
Puts
$280K
Top Buyers
| 1 | +$39.2M | |
| 2 | +$33.4M | |
| 3 | +$30.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.4M |
Top Sellers
| 1 | -$43.2M | |
| 2 | -$28.5M | |
| 3 | -$20.8M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$10.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$10M |